Dana-Farber Cancer Institute at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Dana-Farber Cancer Institute brings 3 presentations to ENA 2026 in Barcelona. Its program centres on antibody-drug conjugates and gynecologic cancers, including Nectin-4 as a target in vulvar squamous cell carcinoma. It also covers SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer.
| Organization | ENA 2026 Attendance |
|---|---|
Dana-Farber Cancer Institute Boston, MA | |
Harvard-affiliated cancer treatment and research centre. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Talk Thu Nov 19 12:30–12:50pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm |
Instantly find 20 buyers from Dana-Farber Cancer Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction